In pancreatic cancer, a transcriptomic signature of replication stress that predicts response to ATR and WEE1 inhibitors has been reported, which, similar to our findings, was not associated with homologous recombination deficiency40. This evidence concerns the gene ATR and familial pancreatic carcinoma.